Successful implantation of heart pump with power cable behind the ear, a Japan first!

December 04, 2017

In March 2017, the Cardiovascular Surgery Group at Osaka University successfully implanted a left ventricular assist device with an internal power cable tunneled through the neck to the head in a patient who was ineligible for a cardiac transplantation, destination therapy (DT) trial, a Japan first. The patient was recently discharged.

Under the system to provide medical treatment to end-stage heart failure patients, a group that is ineligible for heart transplantation, in response to their requests, Osaka University Hospital gained the nation's first approval for its use as a medical device on February 20, 2017.

A group of researchers led by Prof. Yoshiki SAWA implanted a left ventricular assist device with an internal power cable tunneled through the neck to the head in a patient with severe kidney disease who was ineligible for destination therapy (DT) for cardiac transplantation.

Thus far, patients with previous diseases such as irreversible kidney disorder were ineligible for a heart transplant or destination therapy. In addition, in Japan, the use of left ventricular assist devices was approved as just a bridge to a heart transplant and was not covered by National Health Insurance. Using this system upon request from a patient, it has become possible to treat the patient ineligible for a heart transplant or destination therapy and use this technique for tunneling the internal power cable through the neck to the head, which is approved overseas, but not in Japan.

Compared to currently approved treatment using an electrical cord connected at an abdominal site, this new method has a low risk of developing infectious diseases due to the power cable behind the ear and is anticipated to improve patients' quality of life; for example, patients with this new device can soak in a bathtub as most Japanese people do when taking a bath. This method will provide many people with difficult disease such as severe heart failure with a new option of therapy with left ventricular assist devices.
-end-


Osaka University

Related Heart Transplant Articles from Brightsurf:

Does the new heart transplant allocation policy encourage gaming by providers?
A new national policy was created to make determining who receives a heart transplant more fair.

Tiny biological package gets drug right to the 'heart' of transplant rejection
For patients who receive a heart transplant in the near future, the old adage, 'Good things come in small packages,' may become words to live by.

Survival on heart transplant waiting list
Survival of patients on the heart transplant waiting list was examined in this observational study.

Double surgery improves chances for heart transplant in patients with obesity
Pairing bariatric surgery with LVAD heart surgery may be an effective bridge to heart transplant for obese patients.

Changes in US heart transplant waitlist activity, volume during COVID-19 pandemic
National and regional changes in waitlist inactivations and additions, donor recovery and heart transplant volume during the COVID-19 pandemic are described in this observational study.

Racial, gender disparities observed in heart transplant recipients with COVID-19 infection
Researchers suggest focusing on disparities to help identify which patients with a heart transplant may be at higher risk for a worse course of COVID-19 infection.

Characteristics, outcomes of heart transplant recipients with COVID-19
The characteristics, treatment and outcomes of heart transplant recipients who were infected with COVID-19 in New York City are described in this case series.

PET imaging offers new insights into post-transplant care for heart patients
Myocardial blood flow (MBF) and myocardial flow reserve (MFR) have been identified as accurate indicators for graft failure after cardiac transplantation, according to research published in The Journal of Nuclear Medicine.

Massachusetts General Hospital performs first-of-its-kind heart transplant in New England
Mass General Hospital recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts.

Air pollution may increase mortality risk after heart transplant
Heart transplant recipients who live in areas where particulate matter (PM2.5) air pollution levels reached above national limits for clean air had a 26% higher risk of mortality due to infection, according to a study published today in the Journal of the American College of Cardiology.

Read More: Heart Transplant News and Heart Transplant Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.